Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013

The Melanoma Independent Board (MIB) held its first conference from 21 to 22 October, 2013, in Rome, Italy. Like the MIB itself, the conference brought together specialists from all aspects of cancer care: doctors, patient associations, journalists, and representatives from local government, hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Testori, A, Ascierto, P, Chiarion Sileni, V, De Lorenzo, F, Pelicci, PG, Rossi, CR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2014
Materias:
Conference Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096026/
https://www.ncbi.nlm.nih.gov/pubmed/25075214
http://dx.doi.org/10.3332/ecancer.2014.440
_version_ 1782326113317421056
author Testori, A
Ascierto, P
Chiarion Sileni, V
De Lorenzo, F
Pelicci, PG
Rossi, CR
author_facet Testori, A
Ascierto, P
Chiarion Sileni, V
De Lorenzo, F
Pelicci, PG
Rossi, CR
author_sort Testori, A
collection PubMed
description The Melanoma Independent Board (MIB) held its first conference from 21 to 22 October, 2013, in Rome, Italy. Like the MIB itself, the conference brought together specialists from all aspects of cancer care: doctors, patient associations, journalists, and representatives from local government, hospitals, and pharma to encourage an interdisciplinary discussion on the future of melanoma. It was hoped that the conference would be an opportunity for all participants to see and understand each other’s points of view. In memoriam of melanoma pioneer Natalie Cascinelli, the conference focussed on innovation and sustainability as well as the latest drug developments.
format Online
Article
Text
id pubmed-4096026
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-40960262014-07-29 Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013 Testori, A Ascierto, P Chiarion Sileni, V De Lorenzo, F Pelicci, PG Rossi, CR Ecancermedicalscience Conference Report The Melanoma Independent Board (MIB) held its first conference from 21 to 22 October, 2013, in Rome, Italy. Like the MIB itself, the conference brought together specialists from all aspects of cancer care: doctors, patient associations, journalists, and representatives from local government, hospitals, and pharma to encourage an interdisciplinary discussion on the future of melanoma. It was hoped that the conference would be an opportunity for all participants to see and understand each other’s points of view. In memoriam of melanoma pioneer Natalie Cascinelli, the conference focussed on innovation and sustainability as well as the latest drug developments. Cancer Intelligence 2014-06-30 /pmc/articles/PMC4096026/ /pubmed/25075214 http://dx.doi.org/10.3332/ecancer.2014.440 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Conference Report
Testori, A
Ascierto, P
Chiarion Sileni, V
De Lorenzo, F
Pelicci, PG
Rossi, CR
Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013
title Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013
title_full Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013
title_fullStr Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013
title_full_unstemmed Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013
title_short Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013
title_sort report from the melanoma independent board first melanoma mib conference, 21–22 october 2013
topic Conference Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096026/
https://www.ncbi.nlm.nih.gov/pubmed/25075214
http://dx.doi.org/10.3332/ecancer.2014.440
work_keys_str_mv AT testoria reportfromthemelanomaindependentboardfirstmelanomamibconference2122october2013
AT asciertop reportfromthemelanomaindependentboardfirstmelanomamibconference2122october2013
AT chiarionsileniv reportfromthemelanomaindependentboardfirstmelanomamibconference2122october2013
AT delorenzof reportfromthemelanomaindependentboardfirstmelanomamibconference2122october2013
AT peliccipg reportfromthemelanomaindependentboardfirstmelanomamibconference2122october2013
AT rossicr reportfromthemelanomaindependentboardfirstmelanomamibconference2122october2013

Ejemplares similares